39 results
8-K
EX-1.1
TRML
Tourmaline Bio Inc
26 Jan 24
Other Events
4:12pm
and, if due and payable, any related or similar assessment, fine or penalty levied against any of them except as may be being contested in good faith
424B5
TRML
Tourmaline Bio Inc
26 Jan 24
Prospectus supplement for primary offering
4:08pm
; and
an exemption from the auditor attestation requirement in the assessment of our internal control over financial reporting.
We may take advantage
424B5
14kis z799ad
24 Jan 24
Prospectus supplement for primary offering
9:20pm
8-K
EX-99.1
j9r5vcdyea 5d
24 Jan 24
Results of Operations and Financial Condition
5:10pm
424B3
aew7zggr
15 Sep 23
Prospectus supplement
6:31am
425
r2z9ioqioljzi791i9gl
13 Sep 23
Business combination disclosure
9:14am
8-K
EX-99.1
x9d6oz7q9n 8nz
13 Sep 23
Regulation FD Disclosure
9:13am
S-4/A
4yfsjppm
25 Aug 23
Registration of securities issued in business combination transactions (amended)
4:34pm
S-4
drwoqnsreujqes
19 Jul 23
Registration of securities issued in business combination transactions
7:57pm
425
iz3tq wxeu3z37jbcj5q
22 Jun 23
Business combination disclosure
9:12am
8-K
EX-2.1
hiwyyr
22 Jun 23
Talaris Therapeutics and Tourmaline Bio Announce Merger Agreement
9:10am